SYDNEY — Three variants of Medik8 Physical Sunscreen SPF50+ are being urgently recalled in Australia and New Zealand after testing showed the products may not deliver the level of sun protection claimed on their labels, the Therapeutic Goods Administration announced.

AC Newco Pty Ltd, trading as Advanced Cosmeceuticals and acting on behalf of the UK-based skincare brand Medik8, initiated the voluntary recall of all unexpired batches of the affected sunscreens on April 1, 2026. The recall covers five specific batches across three products: the standard Physical Sunscreen SPF50+ 60mL, the Professional version 60mL, and the 15mL “Try Me” size often included in post-treatment kits.

The TGA warning states the products are “unlikely to meet their labelled Sun Protection Factor (SPF) rating.” A lower-than-advertised SPF increases the risk of sunburn during use and may reduce long-term protection against skin cancer, the agency noted.

Affected batches include:

• Physical Sunscreen SPF50+ Professional 60mL (ARTG 331064): Batch A1798B (expiry August 2026) and Batch A2651A (expiry April 2028)
• Physical Sunscreen SPF50+ 60mL (ARTG 331064): Batch A1798B and Batch A2651B (both with August 2026 or April 2028 expiry dates)
• Physical Sunscreen SPF50+ Try Me 15mL (ARTG 331064): Affected batches included in certain kits

The products were sold in Australia and New Zealand between August 2023 and March 2026. Consumers who purchased any of these items are urged to stop using them immediately and return them to the place of purchase for a full refund. Alternatively, they can contact the recall hotline at 02 7248 5617 or email medik8spfrecall@acskingroup.com, providing proof of purchase or a photo of the product and batch details.

Medik8 described the action as a precautionary measure following updated independent SPF testing. In a statement shared with media outlets, the brand emphasized its commitment to product safety and quality. “We are voluntarily recalling Medik8 Physical Sunscreen SPF 50 from the Australian and New Zealand market,” the company told Allure magazine. No similar recall has been announced for other markets where the sunscreen is sold.

The recall highlights ongoing scrutiny of sunscreen efficacy in Australia, a country with one of the highest rates of skin cancer in the world. Australian sunscreen standards are among the strictest globally, requiring products to undergo rigorous in-vitro and in-vivo testing to verify SPF claims. The TGA regularly monitors compliance and has issued previous recalls for sunscreens failing to meet labeled protection levels.

Dermatologists and skin cancer experts stressed the importance of using reliable sunscreens. “An SPF50+ product that underperforms could leave users with a false sense of security, especially during peak UV hours,” said Dr. Elena Thompson, a Sydney-based dermatologist. “Broad-spectrum protection against UVA and UVB rays is critical, and consumers should always check for the Australian TGA listing number on the packaging.”

The affected Medik8 sunscreen is a physical (mineral) formula relying on zinc oxide and titanium dioxide for protection. These ingredients sit on the skin’s surface to reflect UV rays rather than absorbing them, making the product popular among those with sensitive skin. However, formulation stability, particle size and proper application all influence real-world performance.

Consumers with the recalled products should dispose of them safely if a return is not possible, though the TGA encourages returns to facilitate proper accounting and potential further testing. No reports of adverse events linked to the products have been publicly detailed, but the agency advises anyone experiencing unusual skin reactions after use to seek medical advice and report it via the TGA website.

The recall comes during the southern hemisphere’s autumn, but UV levels remain high in many parts of Australia, particularly in northern regions. Health authorities continue to recommend daily sunscreen use as part of sun-safe behavior, alongside protective clothing, hats, sunglasses and seeking shade during peak sun hours (typically 10 a.m. to 3 p.m.).

Medik8, known for its professional-grade skincare focused on ingredients like vitamin C, retinoids and antioxidants, has built a loyal following in Australia through clinics and selected retailers. The brand’s Physical Sunscreen was marketed as a lightweight, non-greasy option suitable for daily wear under makeup or alone.

This is not the first time a premium sunscreen brand has faced SPF-related issues in Australia. Previous recalls have involved both local and imported products, underscoring the challenges of maintaining consistent protection in real-world manufacturing and storage conditions.

The TGA maintains a public database of recalls and safety alerts. Consumers can check the agency’s website or the product’s ARTG entry (331064) for the latest updates. Pharmacies and retailers that stocked the Medik8 sunscreen have been notified and are expected to remove affected stock from shelves.

For those seeking alternatives, the TGA recommends choosing sunscreens with clear SPF50+ or SPF50 labeling, broad-spectrum protection and a visible ARTG number. Water-resistant formulas may be preferable for outdoor activities, but all sunscreens should be reapplied every two hours or after swimming or sweating.

Skin cancer prevention remains a public health priority in Australia, with campaigns like Slip, Slop, Slap, Seek and Slide reinforcing comprehensive sun protection strategies. Experts note that no sunscreen offers 100% protection, making layered approaches essential.

As the recall progresses, AC Newco and Medik8 are working with the TGA to manage returns and refunds efficiently. The company has assured customers that other Medik8 products are unaffected and continue to meet all safety and efficacy standards.

Consumers with questions about the recall or concerns about sun protection are encouraged to consult their pharmacist, dermatologist or visit the TGA website for further guidance. With skin cancer rates remaining high, authorities stress the importance of using verified, effective sunscreens as part of daily routines.

The incident serves as a reminder that even established brands can face quality control challenges, and regulatory oversight plays a vital role in protecting public health. Australians are advised to stay vigilant with product recalls and prioritize sun safety measures throughout the year.